Lung Ultrasound (LUS) has been revealing an extremely useful tool to identify and monitor complications from Sars-COV-2 disease. Recently, a research group has proposed a score, named LUS Score, able to optimize the use of this diagnostic technique. LUS Score is computed analyzing chest posterior and lateral spaces, considering the number of artefacts generated by the inflammed interstitium (B lines), the characteristics of the pleural line and the presence or not of consolidation areas. The comparison between LUS and chest tomography (CT), the current gold standard for the diagnosis of interstitial pneumonia by COVID-19, has confirmed from the preliminary data, the reliability of such technique. Hence, the validation on a really large sample size of the ultrasound tool performed by dedicated personnel with high expertise, may allow the validation both in the clinical practice and in emergency and ordinary wards.
Study Type
OBSERVATIONAL
Enrollment
950
the patients underwent to a non invasive diagnostic exam to identify and monitor clinical conditions and onset of respiratory complications due to COVID-19
University of Campania Luigi Vanvitelli
Naples, Campania, Italy
validation of lung ultrasound score
validation of lung ultrasound in the clinical practice of diagnosis of complications of low respiratory tracts during COVID-19
Time frame: 6 months
Association of LUS score with clinical outcome
assessment of LUS score association with the clinical course of disease (final outcome, either discharged or in-hospital mortality
Time frame: 6 months
Association of LUS score with duration of hospitalization (days)
assessment of LUS score association with hospitalization days
Time frame: 6 months
Association of LUS score with respiratory support required
assessment of LUS score association with requirement of either sub-intensive or intensive therapy)
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.